Semigran Marc

Insider Reports History

Entity
Individual
Location
C/O Myokardia, Inc., 333 Allerton Ave, South San Francisco, CA
Signature
/s/ John R. Moore, Attorney-in-Fact for Semigran Marc
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Semigran Marc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. Chief Development Officer Restricted Stock Units 23.1K $437K $18.91 Aug 12, 2024 Direct
Edgewise Therapeutics, Inc. Chief Development Officer Stock Option (Right to Buy) 139K Aug 12, 2024 Direct
Renovacor, Inc. Chief Medical Officer Common Stock 0 $8.00 Dec 1, 2022 Direct
Renovacor, Inc. Chief Medical Officer Stock Option 0 Dec 1, 2022 Direct

Insider Reports Filed by Semigran Marc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EWTX Edgewise Therapeutics, Inc. Aug 12, 2024 2 $0 4 Aug 14, 2024 Chief Development Officer
EWTX Edgewise Therapeutics, Inc. Aug 17, 2023 1 $0 4 Aug 18, 2023 Chief Development Officer
EWTX Edgewise Therapeutics, Inc. Dec 30, 2022 1 $0 4 Jan 3, 2023 Chief Development Officer
EWTX Edgewise Therapeutics, Inc. Dec 19, 2022 0 $0 3 Dec 22, 2022 Chief Development Officer
RCOR Renovacor, Inc. Dec 1, 2022 6 $0 4 Dec 5, 2022 Chief Medical Officer
RCOR Renovacor, Inc. Jan 24, 2022 2 $0 4 Jan 26, 2022 Chief Medical Officer
RCOR Renovacor, Inc. Dec 20, 2021 1 $0 4 Dec 22, 2021 Chief Medical Officer
RCOR Renovacor, Inc. Sep 3, 2021 1 $0 4 Sep 8, 2021 Chief Medical Officer
RCOR Renovacor, Inc. Sep 2, 2021 0 $0 3 Sep 7, 2021 Chief Medical Officer
PROK Social Capital Suvretta Holdings Corp. III Jun 29, 2021 0 $0 3 Jun 29, 2021 Director